Brexogen
Seoul
About Brexogen
Brexogen is a biotechnology cell therapy research and development company.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $9.1M
- Funding stage: Late Stage Venture
- Last round: Series C (Sep 2023)
- Website: brexogen.com
- Phone: +82 2 430 0401
Industries & Categories
Biopharma, Biotechnology, Medical
Canonical: https://fsome.com/organization/brexogen-115001 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.